We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Nurix Therapeutics
NRIX
$2.41B
| $854K | ﹤0.01% |
92,445
+16,722
| +22% | +$174K |
|
827
Leonardo DRS
DRS
$12.3B
| $850K | ﹤0.01% |
18,720
-586
| -3% | -$25.5K |
|
828
Capitol Federal Financial
CFFN
$1.09B
| $840K | ﹤0.01% |
132,281
+12,451
| +10% | +$77.8K |
|
|
FSUN
829
FirstSun Capital Bancorp
FSUN
$1.91B
| $836K | ﹤0.01% |
+21,551
| New | +$811K |
|
830
VSE Corp
VSEC
$5.45B
| $834K | ﹤0.01% |
+5,015
| New | +$765K |
|
831
Emergent Biosolutions
EBS
$373M
| $831K | ﹤0.01% |
94,221
+16,314
| +21% | +$127K |
|
832
Stoke Therapeutics
STOK
$1.8B
| $830K | ﹤0.01% |
35,327
-16,131
| -31% | -$276K |
|
833
Xencor
XNCR
$1.5B
| $820K | ﹤0.01% |
69,876
-20,723
| -23% | -$180K |
|
834
Myriad Genetics
MYGN
$270M
| $815K | ﹤0.01% |
112,785
-163
| -0.1% | -$968 |
|
835
Verastem
VSTM
$510M
| $811K | ﹤0.01% |
91,852
-12,998
| -12% | -$96.7K |
|
836
TFS Financial
TFSL
$5.16B
| $799K | ﹤0.01% |
60,613
+5,113
| +9% | +$67.6K |
|
837
Relay Therapeutics
RLAY
$4.1B
| $791K | ﹤0.01% |
151,575
-30,382
| -17% | -$116K |
|
|
VTLE
838
DELISTED
Vital Energy
VTLE
| $787K | ﹤0.01% |
46,608
+17,071
| +58% | +$288K |
|
839
Taysha Gene Therapies
TSHA
$1.68B
| $784K | ﹤0.01% |
239,785
+121,102
| +102% | +$343K |
|
840
AAR Corp
AIR
$5.59B
| $771K | ﹤0.01% |
8,594
-597
| -6% | -$45.4K |
|
|
AMWD
841
DELISTED
American Woodmark
AMWD
| $769K | ﹤0.01% |
11,519
+6,293
| +120% | +$386K |
|
842
TriCo Bancshares
TCBK
$1.84B
| $760K | ﹤0.01% |
17,106
+525
| +3% | +$22.8K |
|
843
Henry Schein
HSIC
$9.77B
| $759K | ﹤0.01% |
11,437
-1,424
| -11% | -$98.6K |
|
844
A.O. Smith
AOS
$8.17B
| $754K | ﹤0.01% |
10,273
-229
| -2% | -$16.3K |
|
845
Conagra Brands
CAG
$6.94B
| $748K | ﹤0.01% |
40,827
+382
| +0.9% | +$7.32K |
|
846
Match Group
MTCH
$9.19B
| $724K | ﹤0.01% |
20,503
-275
| -1% | -$9.81K |
|
847
Casey's General Stores
CASY
$32.2B
| $723K | ﹤0.01% |
1,279
-88
| -6% | -$46K |
|
|
KALV
848
DELISTED
KalVista Pharmaceuticals
KALV
| $704K | ﹤0.01% |
57,790
+10,889
| +23% | +$150K |
|
849
LKQ Corp
LKQ
$5.68B
| $702K | ﹤0.01% |
22,992
+211
| +0.9% | +$6.93K |
|
|
FFWM
850
DELISTED
First Foundation Inc
FFWM
| $698K | ﹤0.01% |
125,313
+18,726
| +18% | +$103K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.